The enhancement of stability of p53 in MTBP induced p53-MDM2 regulatory network

被引:13
|
作者
Alam, Md. Jahoor [1 ]
Fatima, Nishat [1 ]
Devi, Gurumayum Reenaroy [1 ]
Ravins [1 ]
Singh, R. K. Brojen [1 ]
机构
[1] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India
关键词
Unstable and stable states; Limit cycle; Fix point oscillation; Noise parameters; Steady state solutions; STOCHASTIC SIMULATION; G(1) ARREST; MDM2; PROTEIN; APOPTOSIS; CELLS;
D O I
10.1016/j.biosystems.2012.09.005
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
We have modeled an MTBP-MDM2-p53 regulatory network by integrating p53-MDM2 autoregulatory model (Proctor and Gray, 2008) with the effect of a cellular protein MTBP (MDM2 binding protein) which is allowed to bind with MDM2 (Brady et al., 2005). We study this model to investigate the activation of p53 and MDM2 steady state levels induced by MTBP protein under different stress conditions. Our simulation results in three approaches namely deterministic, Chemical Langevin equation and stochastic simulation of Master equation show a clear transition from damped limit cycle oscillation to fixed point oscillation during a certain time period with constant stress condition in the cell. This transition is the signature of transition of p53 and MDM2 levels from activated state to stabilized steady state levels. We present various phase diagrams to show the transition between unstable and stable states of p$3 and MDM2 concentration levels and also their possible relations among critical value of the parameters at which the respective protein level reach stable steady states. In the stochastic approach, the dynamics of the proteins become noise induced process depending on the system size. We found that this noise enhances the stability of the p53 steady state level. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:74 / 83
页数:10
相关论文
共 50 条
  • [31] Relevance of the p53-MDM2 axis to aging
    Wu, Danyi
    Prives, Carol
    CELL DEATH AND DIFFERENTIATION, 2018, 25 (01): : 169 - 179
  • [32] Small molecule inhibitors of the p53-MDM2
    Hu, Chun-Qi
    Hu, Yong-Zhou
    CURRENT MEDICINAL CHEMISTRY, 2008, 15 (17) : 1720 - 1730
  • [33] p53-Mdm2 - the affair that never ends
    Alarcon-Vargas, D
    Ronai, Z
    CARCINOGENESIS, 2002, 23 (04) : 541 - 547
  • [34] Dynamics in the p53-Mdm2 ubiquitination pathway
    Brooks, CL
    Gu, W
    CELL CYCLE, 2004, 3 (07) : 895 - 899
  • [35] The p53-MDM2 interaction in adult medulloblastomas
    Giordana, MT
    Schiffer, P
    Boghi, A
    Pradotto, L
    Morra, I
    Mauro, A
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2000, 59 (05): : 447 - 447
  • [36] Oscillations by the p53-Mdm2 feedback loop
    Lahav, Galit
    CELLULAR OSCILLATORY MECHANISMS, 2008, 641 : 28 - 38
  • [37] The p53-Mdm2 module and the ubiquitin system
    Michael, D
    Oren, M
    SEMINARS IN CANCER BIOLOGY, 2003, 13 (01) : 49 - 58
  • [38] Screening of medicinal plant phytochemicals as natural antagonists of p53-MDM2 interaction to reactivate p53 functioning
    Riaz, Muhammad
    Ashfaq, Usman A.
    Qasim, Muhammad
    Yasmeen, Erum
    Ul Qamar, Muhammad T.
    Anwar, Farooq
    ANTI-CANCER DRUGS, 2017, 28 (09) : 1032 - 1038
  • [39] In silico criterion for prediction of effects of p53 gene missense mutations on p53-Mdm2 feedback loop
    Veljkovic, Nevena
    Perovic, Vladimir
    PROTEIN AND PEPTIDE LETTERS, 2006, 13 (08): : 807 - 814
  • [40] Inhibition of p53-Mdm2 Interaction by Ellagitannins
    Tatsuda, D.
    Umezawa, Y.
    Iijima, M.
    Momose, I.
    Nomoto, A.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 66 - 66